203 related items for PubMed ID: 37824465
1. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
PLoS One; 2023; 18(10):e0292653. PubMed ID: 37824465
[Abstract] [Full Text] [Related]
2. Combination of S100A12/TLR2 signaling molecules and clinical indicators in a new predictive model for IVIG-resistant Kawasaki disease.
Wu Y, Liu P, Zhou Y, Yang Y, Li S, Yin W, Liu F, Ding Y.
Sci Rep; 2024 Mar 27; 14(1):7261. PubMed ID: 38538656
[Abstract] [Full Text] [Related]
3. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 27; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
4. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
5. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
6. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J, Liu P, Hu W, Xu Y, Deng J.
Clin Rheumatol; 2021 Oct 21; 40(10):4191-4197. PubMed ID: 34059986
[Abstract] [Full Text] [Related]
7. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
Shuai S, Zhang H, Zhang R, Tang M, Luo E, Yang Y, Gao Y, Yue S, Liang H, Cai J.
J Pediatr (Rio J); 2023 Oct 21; 99(4):406-412. PubMed ID: 36977496
[Abstract] [Full Text] [Related]
8. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
Ann Med; 2023 Oct 21; 55(2):2264315. PubMed ID: 37870383
[Abstract] [Full Text] [Related]
9. AST-to-ALT ratio and coronary artery lesions among patients with Kawasaki disease.
Cao L, Tang YJ, Gang M, Ma J, Qian WG, Xu QQ, Lv HT.
World J Pediatr; 2021 Dec 21; 17(6):659-668. PubMed ID: 34792780
[Abstract] [Full Text] [Related]
10. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
Int Immunopharmacol; 2023 Sep 21; 122():110600. PubMed ID: 37423157
[Abstract] [Full Text] [Related]
11. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions.
Wang L, Yang Y, Cui Q, Cui Y, Li Q, Che X, Wang C, Quan P, Hu X.
J Investig Med; 2021 Jan 21; 69(1):13-19. PubMed ID: 33004469
[Abstract] [Full Text] [Related]
12. [Predictive value of serum ferritin and a new predictive model for intravenous immunoglobulin resistance in Kawasaki disease].
Zhang YJ, Bai HT, Chen PL.
Zhonghua Er Ke Za Zhi; 2021 Dec 02; 59(12):1080-1085. PubMed ID: 34856668
[Abstract] [Full Text] [Related]
13. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 02; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
14. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
Fu S, Gong F, Xie C, Zhu W, Wang W, Shen H, Tang Y.
Pediatr Res; 2010 Aug 02; 68(2):165-8. PubMed ID: 20461025
[Abstract] [Full Text] [Related]
15. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 02; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
16. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study.
Türkuçar S, Kaya ÜA, Çakmak F, Haşlak F, Demir F, Karabulut E, Makay B, Bilginer Y, Ayaz NA, Sözeri B, Kasapçopur Ö, Karagöz T, Ünal N, Özen S, Ünsal E.
Turk J Pediatr; 2023 Oct 02; 65(1):64-72. PubMed ID: 36866986
[Abstract] [Full Text] [Related]
17. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
Yin W, Wang X, Ding Y, Peng H, Liu YL, Wang RG, Yang YL, Xiong JH, Kang SX.
Indian J Pediatr; 2011 Nov 02; 78(11):1378-82. PubMed ID: 21688043
[Abstract] [Full Text] [Related]
18. Monocyte-Derived Interleukin-1β As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease.
Armaroli G, Verweyen E, Pretzer C, Kessel K, Hirono K, Ichida F, Okabe M, Cabral DA, Foell D, Brown KL, Kessel C.
Arthritis Rheumatol; 2019 May 02; 71(5):792-804. PubMed ID: 30447136
[Abstract] [Full Text] [Related]
19. Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.
Ming L, Cao HL, Li Q, Yu G.
Pediatr Cardiol; 2021 Oct 02; 42(7):1496-1503. PubMed ID: 34036412
[Abstract] [Full Text] [Related]
20. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
Zhang H, Zhang Y.
Zhongguo Dang Dai Er Ke Za Zhi; 2024 May 15; 26(5):461-468. PubMed ID: 38802905
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
